This approach has been successfully employed in diabetes and obesity treatments.[24, 25] We used surface plasmon resonance (SPR) technology to study the binding interaction between VEGF‐B and NRP1 and to measure the direct binding affinity and kinetics between the novel peptides and NRP1. The gene discussed is NRP1; the disease is obesity due to melanocortin 4 receptor deficiency.